文献速递产科母胎医学

III型选择性宫内生长受限单绒毛膜双胎妊娠结局

Outcome of monochorionic twin pregnancy complicated by Type-III selective intrauterine growth restriction.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

这项回顾性多中心研究分析了328例III型sIUGR单绒毛膜双羊膜囊双胎妊娠,发现非医源性宫内死亡率低于既往报道,且随孕周增加而下降;无并发症者计划32周分娩时复合不良新生儿结局风险为29.0%,继续至34周者宫内死亡风险仅0.7%、复合不良新生儿结局风险11%。

要点

  • III型sIUGR双胎非医源性宫内死亡风险随孕周下降,28.4周后低于2%,32.6周后低于1%。
  • 无并发症者32周分娩时复合不良新生儿结局风险为29.0%。
  • 继续至34周者宫内死亡风险0.7%,复合不良新生儿结局风险11%。

核心结论

  • 本队列中III型sIUGR双胎妊娠的胎儿死亡风险低于既往报道。
  • 需进一步识别胎儿死亡预测因素并优化产前监测策略,以筛选可安全继续至33周后的妊娠。

研究设计与样本

  • 回顾性多中心队列研究,纳入9个胎儿中心12年间管理的328例III型sIUGR单绒毛膜双羊膜囊双胎妊娠(656个胎儿)。
  • 排除高级多胎妊娠、重大胎儿畸形或初始即存在其他单绒毛膜相关并发症的妊娠。

主要发现

  • 排除选择性减胎18例(5.5%)后,620个胎儿中非医源性宫内死亡51例(8.2%),310例妊娠中35例(11.3%)发生非医源性宫内死亡。
  • 单胎宫内死亡发生于19/328例妊娠(5.8%),双胎宫内死亡发生于16/328例妊娠(4.9%)。
  • 每胎儿非医源性宫内死亡前瞻性风险从16周的8.1%(95%CI 5.95-10.26%)降至28.4周后的不足2%(95%CI 0.59-2.79%),32.6周后降至不足1%(95%CI -0.30至1.89%)。
  • 无并发症的III型sIUGR妊娠通常计划32周分娩,此时复合不良新生儿结局风险为29.0%(31/107例新生儿)。
  • 继续至34周的双胎妊娠宫内死亡风险极低(0.7%),复合不良新生儿结局风险低(11%)。

关键数值与推荐

  • 复合不良新生儿结局定义为新生儿死亡、复苏期后侵入性通气、培养证实的脓毒症、需治疗的坏死性小肠结肠炎、>I级脑室内出血、>II期早产儿视网膜病变或囊性脑室周围白质软化。
  • 非医源性宫内死亡每胎儿风险:16周8.1%(95%CI 5.95-10.26%),28.4周后<2%(95%CI 0.59-2.79%),32.6周后<1%(95%CI -0.30至1.89%)。
  • 无并发症者32周分娩时复合不良新生儿结局风险29.0%(31/107);继续至34周者宫内死亡风险0.7%、复合不良新生儿结局风险11%。

临床怎么用

  • III型sIUGR双胎妊娠可依据孕周分层评估宫内死亡风险,28.4周后风险低于2%,32.6周后低于1%。
  • 无并发症者计划32周分娩时需权衡29.0%的复合不良新生儿结局风险。
  • 继续至34周者宫内死亡和复合不良新生儿结局风险均较低,提示部分妊娠可安全延长孕周。

局限性

  • 回顾性研究设计, management strategies 经回顾性复习而非预设方案。
  • 数据来自9个三级胎儿中心,外推性需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type-III selective intrauterine growth restriction (sIUGR) is associated with a high and unpredictable risk of fetal death and fetal brain injury. The objective of this study was to describe the prospective risk of fetal death and the risk of adverse neonatal outcome in a cohort of twin pregnancies complicated by Type-III sIUGR and treated according to up-to-date guidelines. METHODS: We reviewed retrospectively all monochorionic diamniotic twin pregnancies complicated by Type-III sIUGR managed at nine fetal centers over a 12-year period. Higher-order multiple gestations and pregnancies with major fetal anomalies or other monochorionicity-related complications at initial presentation were excluded. Data on fetal and neonatal outcomes were collected and management strategies reviewed. Composite adverse neonatal outcome was defined as neonatal death, invasive ventilation beyond the resuscitation period, culture-proven sepsis, necrotizing enterocolitis requiring treatment, intraventricular hemorrhage Grade > I, retinopathy of prematurity Stage > II or cystic periventricular leukomalacia. The prospective risk of intrauterine death (IUD) and the risk of neonatal complications according to gestational age were evaluated. RESULTS: We collected data on 328 pregnancies (656 fetuses). After exclusion of pregnancies that underwent selective reduction (n = 18 (5.5%)), there were 51/620 (8.2%) non-iatrogenic IUDs in 35/310 (11.3%) pregnancies. Single IUD occurred in 19/328 (5.8%) pregnancies and double IUD in 16/328 (4.9%). The prospective risk of non-iatrogenic IUD per fetus declined from 8.1% (95% CI, 5.95-10.26%) at 16 weeks, to less than 2% (95% CI, 0.59-2.79%) after 28.4 weeks and to less than 1% (95% CI, -0.30 to 1.89%) beyond 32.6 weeks. In otherwise uncomplicated pregnancies with Type-III sIUGR, delivery was generally planned at 32 weeks, at which time the risk of composite adverse neonatal outcome was 29.0% (31/107 neonates). In twin pregnancies that continued to 34 weeks, there was a very low risk of IUD (0.7%) and a low risk of composite adverse neonatal outcome (11%). CONCLUSIONS: In this cohort of twin pregnancies complicated by Type-III sIUGR and treated at several tertiary fetal centers, the risk of fetal death was lower than that reported previously. Further efforts should be directed at identifying predictors of fetal death and optimal antenatal surveillance strategies to select a cohort of pregnancies that can continue safely beyond 33 weeks' gestation. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Shinar S, Xing W, Pruthi V, et al. Outcome of monochorionic twin pregnancy complicated by Type-III selective intrauterine growth restriction. Ultrasound Obstet Gynecol. 2021. PMID: 33073883. doi:10.1002/uog.23515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。